Goldman Sachs Group »

Longboard Pharmaceuticals In shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Longboard Pharmaceuticals In (LBPH) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Longboard Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Longboard Pharmaceuticals In held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longboard Pharmaceuticals In by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $83k 14k 6.03
2023-09-30 $62k 11k 5.56
2023-06-30 $80k 11k 7.34
2021-03-31 $410k 25k 16.40

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Ishares Tr CMN (IWM)
Amazon CMN (AMZN)
Nvidia Corporation CMN (NVDA)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IVV)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Vanguard Index Fds CMN (VOO)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Longboard Pharmaceuticals In

Cormorant Asset Management
T. Rowe Price Associates
Ikarian Capital
Point72 Asset Management
Vanguard Group
Jpmorgan Chase & Co
Jennison Associates
TD Asset Management
Schonfeld Strategic Advisors
Bank of New York Mellon
Charles Schwab Investment Management
Walleye Trading Advisors
Dimensional Fund Advisors
Jacobs Levy Equity Management
Laurion Capital Management

View all funds holding Longboard Pharmaceuticals In